FDA Approved: LATANOPROST — Supplemental Application (Bausch & Lomb Incorporated)

View source ↗

Summary

The FDA approved a supplemental application for latanoprost from Bausch & Lomb Incorporated, related to an existing latanoprost therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Latanoprost (Latanoprost)

Snippet

SUPPL AP for LATANOPROST (LATANOPROST)